REVOSS Trademark

Trademark Overview


On Friday, March 19, 2021, a trademark application was filed for REVOSS with the United States Patent and Trademark Office. The USPTO has given the REVOSS trademark a serial number of 90589907. The federal status of this trademark filing is REGISTERED as of Tuesday, March 29, 2022. This trademark is owned by Unicare Biomedical, Inc.. The REVOSS trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft bone and tissue
revoss

General Information


Serial Number90589907
Word MarkREVOSS
Filing DateFriday, March 19, 2021
Status700 - REGISTERED
Status DateTuesday, March 29, 2022
Registration Number6688240
Registration DateTuesday, March 29, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 30, 2021

Trademark Statements


Goods and ServicesHuman allograft bone and tissue

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 22, 2021
Primary Code005
First Use Anywhere DateWednesday, June 30, 2021
First Use In Commerce DateThursday, July 1, 2021

Trademark Owner History


Party NameUnicare Biomedical, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLaguna Hills, CA 92653

Party NameUnicare Biomedical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLaguna Hills, CA 92653

Party NameUnicare Biomedical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLaguna Hills, CA 92653

Trademark Events


Event DateEvent Description
Tuesday, March 29, 2022REGISTERED-PRINCIPAL REGISTER
Friday, February 25, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, February 24, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 24, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 2, 2022USE AMENDMENT FILED
Wednesday, February 23, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 2, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, January 25, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 30, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 30, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 22, 2021ASSIGNED TO EXAMINER
Tuesday, June 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 23, 2021NEW APPLICATION ENTERED IN TRAM

Related Keywords


revoss tissue bone allograft human